Ajanta Pharma's Generic Varenicline Tartrate Receives Approval in the U.S
Ajanta Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.
Ajanta Pharma has posted net profit of Rs. 195.30 crores for the period ended September 30, 2023 as against net profit of Rs. 208.12 crores for the period ended June 30, 2023. The company posted net profit of Rs.156.60 crores for the period ended September 30, 2022.
Ajanta Pharma's Generic Topiramate Receives Approval in US
Ajanta Pharma looks to expand ops in high-growth Asian, African geographies
The US FDA audit was conducted by the officials from 19 June 2023 to 23rd June 2023, said the pharma company in its stock filing.
Ajanta's Generic Pantoprazole Sodium Receives Approval in the U.S.
Ajanta`s Generic Brexpiprazole Receives Approval in the U.S.
Ajanta's Generic Fluphenazine Hydrochloride Receives Approval in the U.S.